Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Illumina Inc
(NQ:
ILMN
)
111.07
-3.39 (-2.96%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Illumina Inc
< Previous
1
2
...
10
11
12
13
14
15
16
17
Next >
Why Are Illumina Shares Trading Higher Today?
January 11, 2022
At the J.P. Morgan Healthcare Conference, Illumina Inc (NASDAQ: ILMN) said it expects about $4.517 billion, +39% Y/Y in 2021 revenue after the company logged...
Via
Benzinga
10 Biggest Price Target Changes For Tuesday
January 11, 2022
Keybanc cut the price target for Netflix, Inc. (NASDAQ:
Via
Benzinga
21 Stocks Moving in Tuesday's Pre-Market Session
January 11, 2022
Gainers OneSmart International Education Group Limited (NYSE: ONE) rose 39.1% to $0.2701 in pre-market trading. OneSmart International Education Group received notification from...
Via
Benzinga
A Peek Into The Markets: US Stock Futures Higher Ahead Of Powell
January 11, 2022
Pre-open movers U.S. stock futures traded higher in early pre-market trade after the Dow Jones dipped more than 160 points in the previous session. Investors are awaiting earnings...
Via
Benzinga
5 Stocks To Watch For January 11, 2022
January 11, 2022
Some of the stocks that may grab investor focus today are: Wall Street expects TD SYNNEX Corporation (NYSE: SNX) to report quarterly earnings at $2.67 per share on revenue of $...
Via
Benzinga
Start Of The Week
January 10, 2022
British property (real estate) stocks fell today.
Via
Talk Markets
12 Health Care Stocks Moving In Monday's After-Market Session
January 10, 2022
Gainers Inari Medical (NASDAQ:NARI) stock...
Via
Benzinga
Why Jim Cramer Likes Illumina And Enterprise Products Partners
January 06, 2022
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Illumina, Inc. (NASDAQ:
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 7, 2022
January 07, 2022
Upgrades According to Wolfe Research, the prior rating for CVR Energy Inc (NYSE:
Via
Benzinga
The Daily Biotech Pulse: Lilly Strikes Neurological R&D Collaboration, Valneva Confirms Vaccine Timelines, Biohaven Gains On Strong Migraine Drug Sales
January 06, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Illumina Announces Co-Development Partnership With SomaScan For Accelerating...
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
January 03, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our...
Via
Benzinga
Why Jim Cramer Likes Illumina, SoFi And More
December 08, 2021
On CNBC’s "Mad Money Lightning Round," Jim Cramer said SoFi Technologies, Inc’s (NASDAQ:
Via
Benzinga
Bionano Genomics Proves Not Everything Genetic is Gold
December 01, 2021
Bionano sells a $150,000 machine called Saphyr that does genetic mapping. It's a solid device, but its future remains in the future, as do BNGO stock fortunes.
Via
InvestorPlace
10x Genomics Stock: Bull vs. Bear
November 24, 2021
After a hot start, the stock has recently lagged the market. Is now a good time to buy?
Via
The Motley Fool
Topics
Initial Public Offering
Exposures
Securities Market
Wait for Bionano Stock to Fall Further Before Buying
November 23, 2021
BNGO stock is breaking down following the latest earnings report, and there are no major catalysts to push shares up in the short term.
Via
InvestorPlace
Following Rough Year, Is Burning Rock Set To Turn The Corner?
November 18, 2021
Key Takeaways: Burning Rock expects fourth-quarter revenue to grow just 6% year-on-year due to latest Covid-related travel restrictions in China Cancer testing specialist’s...
Via
Benzinga
Europe To Layout Objections to Illumina-Grail Deal: Bloomberg
November 16, 2021
Illumina Inc (NASDAQ: ILMN) says the European Union will issue a list of objections tomorrow over the Company's $8B takeover of GRAIL, Bloomberg reports. Related...
Via
Benzinga
Illumina Clocks 40% Growth In Q3; Earnings Beat Expectations
November 05, 2021
Illumina Inc (NASDAQ: ILMN) reported Q3 revenues of $1.11 billion, +40% Y/Y, beating the consensus of $1.04 billion. Consolidated Product revenues were $978 million,...
Via
Benzinga
Topics
Earnings
Exposures
Financial
Illumina, inc (ILMN) Q3 2021 Earnings Call Transcript
November 04, 2021
ILMN earnings call for the period ending September 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
After Its Grail Buyout, Illumina Beats Third-Quarter Expectations
November 04, 2021
Illumina stock inched higher late Thursday after the company beat forecasts.
Via
Investor's Business Daily
The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO
November 04, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck's Oral Antiviral COVID-19 Pill Authorized In UK Merck &...
Via
Benzinga
Exposures
COVID-19
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
October 31, 2021
Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc...
Via
Benzinga
'Halftime Report' Final Trades From Oct. 25: Illumina, JPMorgan, And More
October 26, 2021
On CNBC’s "Halftime Report" f...
Via
Benzinga
Bet On Biopharma: Data, Digitization, Discovery
October 16, 2021
The after-effects of pandemic-era policies will be with us for some time — with many supply chains still experiencing significant disruption. The worst of this “scarring” will heal. But the...
Via
Talk Markets
Illumina Insider Sold $1.2M In Company Stock
October 15, 2021
Alexander Aravanis, SVP And Chief Technology Officer at Illumina (NASDAQ:ILMN), made a large insider sell on October 12, according to a new SEC filing. What Happened: A Form 4...
Via
Benzinga
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Why Shares of Ilumina Slumped 11.3% in September
October 06, 2021
The company's merger with GRAIL concerned investors.
Via
The Motley Fool
3 Healthcare Stocks to Buy and Hold for the Next 10 Years
September 28, 2021
Some trends will persist for decades.
Via
The Motley Fool
UK's NHS Launches World's Largest Trial Of Blood Test For 50 Types
September 13, 2021
Britain's National Health Service (NHS) will begin the world's largest trial of Grail Inc's flagship Galleri blood test that can be used to detect...
Via
Benzinga
Illumina, Merck Join Hands For Homologous Recombination Deficiency CDx, Research Assay
September 07, 2021
Illumina Inc (NASDAQ: ILMN) and Merck & Co Inc (NYSE: MRK) provided more details on their partnership to develop and commercialize tests that gauge...
Via
Benzinga
Why Illumina Wants Grail Back So Badly
September 04, 2021
The gene-sequencing giant sees a huge opportunity in diagnostics.
Via
The Motley Fool
< Previous
1
2
...
10
11
12
13
14
15
16
17
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.